solid form of the 4- 2 - 5-methyl-1- (2-naphthalenyl) -1h-pyrazol-3-yl oxy ethyl morpholine hydrochloride salt, process for its preparation, same use and pharmaceutical composition comprising the same

摘要

The present invention relates to solid forms having a low degree of crystallinity or substantially amorphous of the hydrochloride salt of 4-[2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine (P027) and processes for their preparation.